Literature DB >> 19660602

Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry.

Jie Qian1, Akiko Maehara, Gary S Mintz, M Pauliina Margolis, Sinan Biro, Gregg W Stone, Martin B Leon.   

Abstract

The impact of total plaque burden on absolute and relative amounts of each virtual histologic (VH) intravascular ultrasound (IVUS) plaque component has yet to be studied. We analyzed gray-scale and VH-IVUS findings in the first 990 patients enrolled in the 3,000+ patient global VH-IVUS registry. Whole pullback plaque burden and absolute and relative cross-sectional areas of fibrous tissue, fibrofatty plaque, dense calcium, and necrotic core were analyzed using a linear regression statistical model. Overall, absolute cross-sectional areas of each of the 4 plaque components correlated with total plaque cross-sectional area; however, the correlation between fibrous tissue and total plaque cross-sectional area was stronger than the correlation between fibrofatty plaque, dense calcium, or necrotic core and total plaque cross-sectional area. This was also true overall for each of the subgroups analyzed (gender, age, and presence/absence of acute coronary syndromes). Slope of the regression line relating each plaque component to overall plaque mass showed that 50% of the plaque cross-sectional area increase was because of fibrous tissue with a more gradual increase in fibrofatty plaque, dense calcium, and necrotic core. However, when comparing relative amounts of each plaque component with total plaque cross-sectional area, there was no significant relation between the increase in fibrous tissue, fibrofatty plaque, dense calcium, and necrotic core and the increase in total plaque cross-sectional area. In conclusion, only the absolute area of each plaque component correlated to overall plaque area, not the relative amount of each plaque; therefore, VH-IVUS plaque component increases must be analyzed by controlling for increases in plaque mass.

Entities:  

Mesh:

Year:  2009        PMID: 19660602     DOI: 10.1016/j.amjcard.2009.04.012

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Site-specific intravascular ultrasound analysis of remodelling index and calcified necrosis patterns reveals novel blueprints for coronary plaque instability.

Authors:  Scott W Murray; Billal Patel; Rodney H Stables; Raphael A Perry; Nicholas D Palmer
Journal:  Cardiovasc Diagn Ther       Date:  2014-08

2.  A comparison between plaque-based and vessel-based measurement for plaque component using volumetric intravascular ultrasound radiofrequency data analysis.

Authors:  Eun-Seok Shin; Hector M Garcia-Garcia; Scot Garg; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-11       Impact factor: 2.357

3.  Is size really all that matters? Remarks on size and necrotic core content of atherosclerotic plaques.

Authors:  Clemens von Birgelen; Jennifer Huisman; Marc Hartmann
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-31       Impact factor: 2.357

4.  Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.

Authors:  Kohei Wakabayashi; Tsuyoshi Nozue; Shingo Yamamoto; Shinichi Tohyama; Kazuki Fukui; Shigeo Umezawa; Yuko Onishi; Tomoyuki Kunishima; Akira Sato; Shogo Miyake; Yoshihiro Morino; Takao Yamauchi; Toshiya Muramatsu; Kiyoshi Hibi; Mitsuyasu Terashima; Hiroshi Suzuki; Ichiro Michishita
Journal:  J Atheroscler Thromb       Date:  2016-03-31       Impact factor: 4.928

5.  High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics.

Authors:  Tamar S Polonsky; Kiang Liu; Lu Tian; James Carr; Timothy J Carroll; Jarett Berry; Michael H Criqui; Luigi Ferrucci; Jack M Guralnik; Melina R Kibbe; Christopher M Kramer; Feiyu Li; Dongxiang Xu; Xihao Zhao; Chun Yuan; Mary M McDermott
Journal:  Atherosclerosis       Date:  2014-09-02       Impact factor: 5.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.